Medicina
Departamento
Pierre and Marie Curie University
París, FranciaPublicaciones en colaboración con investigadoras/es de Pierre and Marie Curie University (10)
2022
-
Changes in body mass index and clinical outcomes after initiation of contemporary antiretroviral regimens
AIDS (London, England), Vol. 36, Núm. 15, pp. 2107-2119
-
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
Journal of Hepatology, Vol. 76, Núm. 5, pp. 1109-1121
2021
-
Pitolisant for Residual Excessive Daytime Sleepiness in OSA Patients Adhering to CPAP: A Randomized Trial
Chest, Vol. 159, Núm. 4, pp. 1598-1609
-
RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease
Gut, Vol. 70, Núm. 12, pp. 2359-2372
2020
-
Addition of maraviroc versus placebo to standard antiretroviral therapy for initial treatment of advanced HIV infection: A randomized trial
Annals of Internal Medicine, Vol. 172, Núm. 5, pp. 297-305
-
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Nature Reviews Gastroenterology and Hepatology, Vol. 17, Núm. 9, pp. 557-588
2019
-
Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout
Annals of the Rheumatic Diseases, Vol. 78, Núm. 11, pp. 1592-1600
-
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1
Antiviral Research, Vol. 170
2014
-
Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries
AIDS, Vol. 28, Núm. 16, pp. 2461-2473
2011
-
Stimulating healthy tissue regeneration by targeting the 5-HT 2B receptor in chronic liver disease
Nature Medicine, Vol. 17, Núm. 12, pp. 1668-1673